BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36272333)

  • 1. High endothelial venules associated with better prognosis in esophageal squamous cell carcinoma.
    Li H; Tang L; Han X; Zhong L; Gao W; Chen Y; Huang J; Wen Z
    Ann Diagn Pathol; 2022 Dec; 61():152051. PubMed ID: 36272333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative analysis of tertiary lymphoid structures and immune microenvironment in patients with esophageal carcinoma.
    Yao Y; Xuan H; Wang J; Gong L; Gao W
    Tumori; 2023 Oct; 109(5):466-480. PubMed ID: 37249074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of tumor-infiltrating immune cells and PD-L1 expression in esophageal squamous cell carcinoma.
    Jiang Y; Lo AWI; Wong A; Chen W; Wang Y; Lin L; Xu J
    Oncotarget; 2017 May; 8(18):30175-30189. PubMed ID: 28404915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of high-endothelial venules correlates with a favorable immune microenvironment in oral squamous cell carcinoma.
    Wirsing AM; Ervik IK; Seppola M; Uhlin-Hansen L; Steigen SE; Hadler-Olsen E
    Mod Pathol; 2018 Jun; 31(6):910-922. PubMed ID: 29416107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PLEK2 and IFI6, representing mesenchymal and immune-suppressive microenvironment, predicts resistance to neoadjuvant immunotherapy in esophageal squamous cell carcinoma.
    Liu J; Chen H; Qiao G; Zhang JT; Zhang S; Zhu C; Chen Y; Tang J; Li W; Wang S; Tian H; Chen Z; Ma D; Tian J; Wu YL
    Cancer Immunol Immunother; 2023 Apr; 72(4):881-893. PubMed ID: 36121452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High endothelial venules are present in pharyngeal and laryngeal carcinomas and they are associated with better prognosis.
    Karpathiou G; Dumollard JM; Gavid M; Casteillo F; Vieville M; Prades JM; Froudarakis M; Peoc'h M
    Pathol Res Pract; 2021 Apr; 220():153392. PubMed ID: 33647862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B7H4 is associated with stemness and cancer progression in esophageal squamous cell carcinoma.
    Piao L; Yang Z; Jin J; Ni W; Qi W; Xuan Y
    Hum Pathol; 2018 Oct; 80():152-162. PubMed ID: 29885401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tertiary lymphoid structures correlate with enhancement of antitumor immunity in esophageal squamous cell carcinoma.
    Nakamura S; Ohuchida K; Hayashi M; Katayama N; Tsutsumi C; Yamada Y; Hisano K; Okuda S; Ohtsubo Y; Iwamoto C; Torata N; Mizuuchi Y; Shindo K; Nakata K; Moriyama T; Morisaki T; Oda Y; Nakamura M
    Br J Cancer; 2023 Oct; 129(8):1314-1326. PubMed ID: 37604932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.
    Guan S; Wang C; Chen X; Liu B; Tan B; Liu F; Wang D; Han L; Wang L; Huang X; Wang J; Yao B; Shi J; Chen P; Nesa EU; Song Q; Cheng Y
    Tumour Biol; 2016 Apr; 37(4):4383-91. PubMed ID: 26499784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-33-expressing microvascular endothelial cells in human esophageal squamous cell carcinoma: Implications for pathological features and prognosis.
    Liu X; Li Z; Ren J; Cui G
    Microvasc Res; 2023 May; 147():104506. PubMed ID: 36792028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitinase 3-like 1 secreted by peritumoral macrophages in esophageal squamous cell carcinoma is a favorable prognostic factor for survival.
    Xing S; Zheng X; Zeng T; Zeng MS; Zhong Q; Cao YS; Pan KL; Wei C; Hou F; Liu WL
    World J Gastroenterol; 2017 Nov; 23(43):7693-7704. PubMed ID: 29209110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Bmi-1 and PAI-1 in esophageal squamous cell carcinoma.
    Zhang Y; Zhang YL; Chen HM; Pu HW; Ma WJ; Li XM; Ma H; Chen X
    World J Gastroenterol; 2014 May; 20(18):5533-9. PubMed ID: 24833884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of OTX1 promotes tumorigenesis in patients with esophageal squamous cell carcinoma.
    Chai J; Xu T; Yang Y; Yuan Y; Xu J; Liu J; Wang K; Lv Y; Chai J; Kang Y; Chen L; Qin J; Jia Q; Li M
    Pathol Res Pract; 2022 Apr; 232():153841. PubMed ID: 35303522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-infiltrating lymphocyte signature in epithelial and stromal compartments of an esophageal squamous cell carcinoma acidic microenvironment mediated by MCT4.
    Zheng S; Liu T; Li L; Liu Q; Yang L; Zhang Q; Lu X
    Pathol Res Pract; 2022 Aug; 236():153954. PubMed ID: 35667197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of tumor necrosis factor receptor 2 in tissue is associated with progression and prognosis of esophageal squamous cell carcinoma.
    Liu Z; Ma C; Ma G; Sun X; Liu J; Li S; Liu K; Wang J; Yang D
    Hum Pathol; 2018 Oct; 80():179-185. PubMed ID: 29920311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition.
    Wang N; Liu F; Cao F; Jia Y; Wang J; Ma W; Tan B; Wang K; Song Q; Cheng Y
    Cancer Biol Ther; 2015; 16(4):528-40. PubMed ID: 25719728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High endothelial venules in intracranial germinomas: Implications for lymphocytes infiltration.
    Chen H; Li G; Cui Y; Zhang Q; Li B; Liu X
    Cancer Med; 2023 Mar; 12(5):5450-5460. PubMed ID: 36259639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vav1 expression is increased in esophageal squamous cell carcinoma and indicates poor prognosis.
    Zhu X; Jin H; Xia Z; Wu X; Yang M; Zhang H; Shang X; Cheng R; Zhan Z; Yu Z
    Biochem Biophys Res Commun; 2017 Apr; 486(2):571-576. PubMed ID: 28336434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial analysis of stromal signatures identifies invasive front carcinoma-associated fibroblasts as suppressors of anti-tumor immune response in esophageal cancer.
    He JZ; Chen Y; Zeng FM; Huang QF; Zhang HF; Wang SH; Yu SX; Pang XX; Liu Y; Xu XE; Wu JY; Shen WJ; Li ZY; Li EM; Xu LY
    J Exp Clin Cancer Res; 2023 May; 42(1):136. PubMed ID: 37254126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.